Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
United States Antimony Corporation Reports Second Quarter and Six Months Ended June 30, 2026 Financial and Operating Results
-
Intrusion Inc. Reports Second Quarter 2026 Results
-
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
-
Intelligent Protection Management Corp. Reports Second Quarter 2026 Financial Results
-
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
-
SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
-
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
H&R Block Reports Fiscal 2026 Results and Enters Fiscal 2027 with Confidence
-
ERock Reports Second Quarter 2026 Results
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
-
Codexis Reports Second Quarter 2026 Financial Results
-
B&G Foods Reports Financial Results for Second Quarter 2026
-
The Hartford Appoints Priscilla Almodovar To Its Board of Directors
-
NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
-
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
-
ESS Tech, Inc. Announces Second Quarter 2026 Financial Results
-
Energy Vault Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue and Gross Margin Guidance
-
Evolv Technology Reports Second Quarter Financial Results
-
Supermicro Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results
-
Realty Income Announces Proposed Convertible Senior Notes Offering
-
Velo3D Announces Second Quarter 2026 Financial Results
-
Quantinuum Reports Second Quarter 2026 Results
-
TransAct Technologies Reports Preliminary Second Quarter 2026 Financial Results
-
NextNav Inc. Reports Second Quarter 2026 Results and Operational Highlights
-
National CineMedia, Inc. to Acquire Captivate for $275 Million, Creating the Leading Premium Video and Digital Out-of-Home Advertising Platform
-
Allison Declares Quarterly Dividend
-
Inuvo Announces Planned Financial Leadership Transitions
-
Grove Receives NYSE Continued Listing Standards Notice
-
Jack Henry Announces Fiscal 2026 Fourth Quarter and Full-Year Deconversion Revenue Results
-
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Innovative Aerosystems to Change Nasdaq Ticker Symbol to “IA” Following Corporate Rebranding
-
Canterbury Park Holding Corporation Reports Second Quarter Results
-
Agree Realty Declares Monthly Common and Preferred Dividends
-
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
-
Pixelworks Reports Second Quarter 2026 Financial Results
-
High Roller Technologies Advances Planned U.S. Prediction Markets Launch; Reports Second Quarter 2026 Results
-
Inuvo Reports Second Quarter 2026 Results
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2026
-
Anterix Inc. Reports First Quarter Fiscal Year 2027 Results
-
Mobia Medical Reports Second Quarter 2026 Financial Results
-
Factorial Announces Second Quarter 2026 Results
-
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
-
Spectral AI Announces 2026 Second Quarter Financial Results
-
Werner® Announces Quarterly Dividend
-
Comscore Announces ROI Strategy to Transform the Business
-
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
-
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

